Similar articles for PMID: 19210142

Year	Number of Results
1996	1
1997	2
1998	1
1999	1
2000	7
2001	3
2002	12
2003	9
2004	10
2005	4
2006	8
2007	7
2008	13
2009	12
2010	5
2011	6
2012	8
2013	4
2014	6
2015	4
2016	1
2017	3
2018	4
2019	2
2021	3
2024	0

1

Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.

van Hoek M, van Tol A, van Vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM. van Hoek M, et al. Curr Med Res Opin. 2009 Jan;25(1):93-101. doi: 10.1185/03007990802596813. Curr Med Res Opin. 2009. PMID: 19210142 Clinical Trial.

2

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.

Diabetes Atorvastin Lipid Intervention (DALI) Study Group. Diabetes Atorvastin Lipid Intervention (DALI) Study Group. Diabetes Care. 2001 Aug;24(8):1335-41. doi: 10.2337/diacare.24.8.1335. Diabetes Care. 2001. PMID: 11473066 Clinical Trial.

3

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.

Frost RJ, Otto C, Geiss HC, Schwandt P, Parhofer KG. Frost RJ, et al. Am J Cardiol. 2001 Jan 1;87(1):44-8. doi: 10.1016/s0002-9149(00)01270-4. Am J Cardiol. 2001. PMID: 11137832 Clinical Trial.

4

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.

van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM; DALI Study Group. van Venrooij FV, et al. Diabetes Care. 2003 Apr;26(4):1216-23. doi: 10.2337/diacare.26.4.1216. Diabetes Care. 2003. PMID: 12663600 Clinical Trial.

5

A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI).

Jani RH, Pai V, Jha P, Jariwala G, Mukhopadhyay S, Bhansali A, Joshi S. Jani RH, et al. Diabetes Technol Ther. 2014 Feb;16(2):63-71. doi: 10.1089/dia.2013.0253. Epub 2013 Oct 18. Diabetes Technol Ther. 2014. PMID: 24138536 Free PMC article. Clinical Trial.

6

Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.

Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT. Chu CS, et al. Acta Cardiol. 2006 Jun;61(3):263-9. doi: 10.2143/AC.61.3.2014826. Acta Cardiol. 2006. PMID: 16869445 Clinical Trial.

7

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.

Blanco-Colio LM, Martín-Ventura JL, Gómez-Guerrero C, Masramon X, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Egido J. Blanco-Colio LM, et al. Eur J Pharmacol. 2008 May 31;586(1-3):259-65. doi: 10.1016/j.ejphar.2008.02.042. Epub 2008 Feb 26. Eur J Pharmacol. 2008. PMID: 18374327 Clinical Trial.

8

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Brousseau ME, et al. N Engl J Med. 2004 Apr 8;350(15):1505-15. doi: 10.1056/NEJMoa031766. N Engl J Med. 2004. PMID: 15071125 Free article. Clinical Trial.

9

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV. Le NA, et al. Metabolism. 2000 Feb;49(2):167-77. doi: 10.1016/s0026-0495(00)91169-7. Metabolism. 2000. PMID: 10690940 Clinical Trial.

10

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

Dallinga-Thie GM, Berk-Planken II, Bootsma AH, Jansen H; Diabetes Atorvastatin Lipid intervention (DALI) Study Group. Dallinga-Thie GM, et al. Diabetes Care. 2004 Jun;27(6):1358-64. doi: 10.2337/diacare.27.6.1358. Diabetes Care. 2004. PMID: 15161788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year